Results 261 to 270 of about 2,594,817 (409)
A putative binding model of nitazene derivatives at the μ-opioid receptor. [PDF]
Clayton J +6 more
europepmc +1 more source
Defects in the opioid growth factor receptor in human squamous cell carcinoma of the head and neck [PDF]
Patricia J. McLaughlin +4 more
openalex +1 more source
ABSTRACT Objective The real‐world evidence on the association between glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) and cancer risk remains limited and mixed. Methods In 2013–2020 national Medicare claims data, we included cancer‐naïve patients with type 2 diabetes (T2D). We identified those who initiated GLP‐1 RA, sodium‐glucose cotransporter 2
Ying Lu +13 more
wiley +1 more source
Single-molecule methods for characterizing receptor dimers reveal metastable opioid receptor homodimers that induce functional modulation. [PDF]
Zhou P +13 more
europepmc +1 more source
Opioid receptor trafficking and interaction in nociceptors
Xu Zhang, L. Bao, Shuai Li
semanticscholar +1 more source
The study demonstrated that thidiazine compounds potentiated the action of antibiotics. The compounds associated with norfloxacin against S. aureus showed greater significance in relation to the other medications. The indiscriminate use of antibiotics has led to the selection of resistant bacterial strains, significantly reducing the effectiveness of ...
João Arthur de Oliveira Borges +15 more
wiley +1 more source
Single-molecule characterization of opioid receptor heterodimers reveals soluble µ-δ dimer blocker peptide alleviates morphine tolerance. [PDF]
Zhou P +10 more
europepmc +1 more source
DAMGO, a μ‐opioid receptor selective ligand, distinguishes between μ‐and κ‐opioid receptors at a different region from that for the distinction between μ‐ and δ‐opioid receptors [PDF]
Masabumi Minami +6 more
openalex +1 more source

